Researchers have identified a metabolically sensitive cell subtype in the eye's drainage system which shows early signs of ...

Biliary atresia (BA) is a life-threatening liver disease of infancy in which early surgery can restore bile flow but rarely ...

Royal Biologics, a leader in innovative biologic solutions for wound care and tissue repair, today announced it has signed an ...

Extracellular vesicles (EVs), including exosomes, microvesicles, apoptotic bodies, and many other EV subtypes, have emerged ...

This review innovatively proposes the use of electrospinning to fabricate electroactive fibrous scaffolds, which mimic the structure of the extracellular matrix while providing electrical activity, ...

UK biotech Engitix has raised a $25 million series A extension from existing investor Netherton Investments, investing on behalf of BlueCrest Capital Management co-founder Mike Platt. The funding will ...

Engitix Announces $25 Million Series A Extension Financing by Existing Investor Mike Platt to Advance ECM-Targeted ...

Engitix plans to use the funds for preclinical development across its pipeline in solid tumors and fibrosis, and to expand ...

TYBR Health has announced the first US clinical use of the collagen-based tissue protector, B3 GEL System, aimed at ...

StimLabs has announced the launch of Allacor P, a human umbilical cord device designed for acute and chronic wound management ...

StimLabs®, a leading regenerative medicine company, announces the launch of Allacor P, the first medical device ...

StimLabs(R) , a leading regenerative medicine company, announces the launch of Allacor P, the first medical device derived from human umbilical cord extracellular matrix (ECM). Allacor P was awarded ...